Merck’s Anti-Covid Pill Shows Better Effectiveness In Indian Study
Topline
Merck and Ridgeback Biotherapeutics’ Covid-19 antiviral pill molnupiravir reduced the risk of hospitalization by over 65% in a clinical trial conducted by their Indian partner…
Read More...
Read More...